AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

All

Events(339)

Highlight(131)

Highlighted publications(70)

News(61)

Highlighted publication

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Dong Y, Saglietti C, Bayard Q, (…), Gottardo R, Homicsko K, Madissoon E

Nature communications – 2025 May 12

Events

ISREC Foundation Research Seminar, Prof. Gert Attard | May 19th

More information

Events

AGORA PRS Seminar | May 20th

More information

Events

ISREC Foundation Research Seminar, Prof. Nir Friedman | May 20th

More information

Events

Second AGORA Sustainability Day | May 21st

More information

Events

Oncology Grand Rounds, Prof. Irit Ben-Aharon | May 23rd

More information

News

Welcoming Professor Etienne Meylan to AGORA

Events

FameLab Event in Lausanne | May 28

More information

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Scott Lowe | June 5th

More information

Highlighted publication

HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.

Lecointre M, Guillot J, Marcone R, (…), Fournier N, Homicsko K, Hanahan D

Cancer discovery – 2025 Apr 27

Events

Ludwig Distinguished Lecture, Dr. Joe Yeong Poh Sheng | June 12th

More information

Events

Ludwig Distinguished Lecture, Prof. Chris Goodnow | June 19th

More information

Past news

Latest publications

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Dong Y, Saglietti C, Bayard Q, (…), Gottardo R, Homicsko K, Madissoon E

Nature communications – 2025 May 12

Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines with Pulsed Electron FLASH-RT.

Grilj V, Zayas AV, Sesink A, (…), Bochud F, Bourhis J, Herrera FG

Int J Radiat Oncol Biol Phys – 2025 May 2

HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.

Lecointre M, Guillot J, Marcone R, (…), Fournier N, Homicsko K, Hanahan D

Cancer discovery – 2025 Apr 27

Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.

Oh J, Hoelzl J, Carlson JCT, (…), Pittet MJ, Pai SI, Weissleder R

Cell reports. Medicine – 2025 Apr 25

Tumor-Infiltrating Clonal Hematopoiesis.

Pich O, Bernard E, Zagorulya M, (…), Bonnet D, Papaemmanuil E, Swanton C

The New England journal of medicine – 2025 Apr 24